Skip to main content

Table 1 Demographic and neurological characteristics of patient groups.

From: Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study

  

Total group

Treatment-naive

group

Pre-treated

group

  

N = 197

N = 106

N = 91

Gender

Female (%)

151 (76.6)

81 (76.4)

70 (76.9)

 

Male (%)

46 (23.4)

25 (23.6)

21 (23.1)

Age (years)

Mean (SD)

38.6 (9.6)

38.5 (9.9)

38.8 (9.2)

Disease duration (years)*

Mean (SD)

4.3 (4.7)

2.7 (4.0)

6.3 (4.8)

GNDS score*

Mean (SD)

10.34 (5.56)

8.75 (4.60)

12.19 (6.01)

EDSS score

Mean (SD)

2.5 (1.42)

2.2 (1.14)

2.9 (1.65)

ARR

Mean (SD)

1.15 (0.62)

1.13 (0.50)

1.18 (0.73)

  1. SD, standard deviation; GNDS, Guy's Neurological Disability Scale; EDSS, Expanded Disability Status Scale; ARR, annualized relapse rate. *, P < 0.05 for differences between treatment-naïve and pre-treated groups.